Ownership history in Ruffer LLP · 18 quarters on record
This page tracks every 13F SEC filing in which Ruffer LLP reported a position in Bristol Myers Squibb Co COM (BMY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 151,760 | +147,256 | +3269.4% | 0.38% | $6.8M | $43.97 |
| 2023 Q1 | REDUCED | 4,504 | -72,451 | -94.1% | 0.01% | $312K | $60.45 |
| 2022 Q4 | REDUCED | 76,955 | -262,276 | -77.3% | 0.37% | $5.6M | $62.26 |
| 2022 Q3 | REDUCED | 339,231 | -1,207,574 | -78.1% | 1.49% | $23.8M | $61.05 |
As of 2025 Q4 — sorted by position size